Dual anti-platelet therapy remains a cornerstone of the treatment for coronary artery disease. When choosing a second anti-platelet, ticagrelor remains a principal agent after the recent PLATO trial ...
Purpose Few studies have examined how psychosocial risk and protective factors in adolescence shape mental health outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback